Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Ames (1996)
A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.The American journal of cardiology, 77 6
W. Frishman, C. Ram, F. Mcmahon, S. Chrysant, A. Graff, J. Kupiec, H. Hsu (1995)
Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group StudyThe Journal of Clinical Pharmacology, 35
C. Yancy, M. Fowler, W. Colucci (2001)
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.The New England journal of medicine, 344 18
M. Stearne, S. Palmer, M. Hammersley, S. Franklin, R. Spivey, J. Levy, C. Tidy, N. Bell, J. Steemson, B. Barrow, R. Coster, K. Waring, J. Nolan, E. Truscott, N. Walravens, L. Cook, H. Lampard, C. Merle, P. Parker, J. Mcvittie, I. Draisey, L. Murchison, A. Brunt, M. Williams, D. Pearson, X. Petrie, M. Lean, D. Walmsley, M. Lyall, E. Christie, J. Church, E. Thomson, A. Farrow, J. Stowers, M. Stowers, K. McHardy, N. Patterson, A. Wright, N. Levi, A. Shearer, R. Thompson, G. Taylor, S. Rayton, M. Bradbury, A. Glover, A. Smyth-Osbourne, C. Parkes, J. Graham, P. England, S. Gyde, C. Eagle, B. Chakrabarti, J. Smith, J. Sherwell, E. Kohner, A. Dornhurst, M. Doddridge, M. Dumskyj, S. Walji, P. Sharp, M. Sleightholm, G. Vanterpool, C. Rose, G. Frost, M. Roseblade, S. Elliott, S. Forrester, M. Foster, K. Myers, R. Chapman, J. Hayes, R. Henry, M. Featherston, G. Archbold, M. Copeland, R. Harper, I. Richardson, S. Martín, H. Davison, D. Hadden, L. Kennedy, A. Atkinson, A. Culbert, C. Hegan, H. Tennet, N. Webb, I. Robinson, J. Holmes, P. Bell, D. McCance, J. Rutherford, S. Nesbitt, A. Spathis, S. Hyer, M. Nanson, L. James, J. Tyrell, C. Davis, P. Strugnell, M. Booth, H. Petrie, D. Clark, B. Rice, S. Hulland, J. Barron, J. Yudkin, B. Gould, J. Singer, A. Badenock, M. Eckert, K. Alibhai, E. Marriot, C. Cox, R. Price, M. Fernandez, A. Ryle, S. Clarke, G. Wallace, E. Mehmed, S. Macfarlane, R. Greenwood, J. Wilson, M. Denholm, R. Temple, K. Whitfield, F. Johnson, C. Munroe, S. Gorick, E. Duckworth, M. Flatman, S. Rainbow, L. Borthwick, D. Wheatcroft, R. Seaman, R. Christie, W. Wheatcroft, P. Musk, J. White, S. McDougal, M. Bond, P. Raniga, R. Newton, R. Jung, C. Roxburgh, B. Kilgallon, L. Dick, N. Waugh, S. Kilby, A. Ellingford, J. Burns, C. Fox, M. Holloway, H. Coghill, N. Hein, A. Fox, W. Cowan, M. Richard, K. Quested, S. Evans, R. Paisey, N. Brown, A. Tucker, R. Paisey, F. Garrett, J. Hogg, P. Park, K. Williams, Philip Harvey, R. Wilcocks, S. Mason, J. Frost, C. Warren, P. Rocket, L. Bower, J. Roland, D. Brown, J. Youens, K. Stanton-King, H. Mungall, W. Maddison, D. Donnelly, S. King, P. Griffin, S. Smith, S. Church, G. Dunn, Apr Wilson, K. Palmer, P. Brown, D. Humphriss, A. Davidson, R. Rose, L. Armistead, S. Townsend, P. Poon, I. Peacock, N. Culverwell, M. Charlton, B. Connolly, J. Peacock, J. Barrett, J. Wain, W. Beeston, G. King, P. Hill, A. Boulton, A. Robertson, Katoulis, A. Olukoga, H. McDonald, S. Kumar, F. Abouaesha, B. Abuaisha, E. Knowles, S. Higgins, J. Booker, J. Sunter, K. Breislin, R. Parker, P. Raval, J. Curwell, H. Davenport, G. Shawcross, A. Prest, J. Grey, H. Cole, C. Sereviratne, R. Young, T. Dornan, J. Clyne, M. Gibson, I. O'Connell, L. Wong, S. Wilson, K. Wright, C. Wallace, D. McDowell, A. Burden, E. Sellén, R. Gregory, M. Roshan, N. Vaghela, M. Burden, C. Sherriff, J. Clarke, J. Grenfell, J. Tooke, K. Macleod, C. Searnark, M. Rammell, C. Pym, J. Stockman, C. Yeo, J. Piper, L. Leighton, E. Green, M. Hoyle, K. Jones, A. Hudson, A. James, A. Shore, A. Higham, B. Martin (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 317
R. Eckel (1997)
Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.Circulation, 96 9
E. Lewis, L. Hunsicker, W. Al (2002)
Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesAcc Current Journal Review, 11
B. Psaty, N. Smith, D. Siscovick, T. Koepsell, N. Weiss, S. Heckbert, R. Lemaitre, Edward Wagner, C. Furberg (1997)
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.JAMA, 277 9
B. Psaty, C. Furberg, L. Kuller, M. Cushman, P. Savage, D. Levine, D. O'leary, R. Bryan, Melissa Anderson, T. Lumley (2001)
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.Archives of internal medicine, 161 9
C. Laing, R. Unwin (2000)
Are calcium antagonists effective in preventing complications of hypertension and progression of renal disease?Current Opinion in Nephrology and Hypertension, 9
G. Harshfield, F. Treiber (1999)
Racial differences in ambulatory blood pressure monitoring-derived 24 h patterns of blood pressure in adolescents.Blood pressure monitoring, 4 3-4
M. Klag, P. Whelton, Bryan Randall, J. Neaton, F. Brancati, C. Ford, N. Shulman, J. Stamler (1996)
Blood pressure and end-stage renal disease in men.The New England journal of medicine, 334 1
H. Hillege, W. Janssen, A. Bak, G. Diercks, D. Grobbee, H. Crijns, W. Gilst, D. Zeeuw, P. Jong (2001)
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidityJournal of Internal Medicine, 249
H. Sesso, M. Stampfer, B. Rosner, C. Hennekens, J. Gaziano, J. Manson, R. Glynn (2000)
Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in MenHypertension: Journal of the American Heart Association, 36
R. Estacio, B. Jeffers, Nancy Gifford, R. Schrier (2000)
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.Diabetes care, 23 Suppl 2
J. McGill, P. Reilly (2001)
Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertensionClinical Cardiology, 24
B. Brenner, M. Cooper, D. Zeeuw, W. Keane, W. Mitch, H. Parving, G. Remuzzi, S. Snapinn, Zhonxin Zhang, S. Shahinfar (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.The New England journal of medicine, 345 12
B. Neal, S. MacMahon, N. Chapman (2000)
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trialsThe Lancet, 356
C. Mogensen, S. Neldam, I. Tikkanen, S. Oren, R. Viskoper, R. Watts, M. Cooper (2000)
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyBMJ : British Medical Journal, 321
J. Flack, E. Saunders, A. Gradman, W. Kraus, F. Lester, J. Pratt, M. Alderman, S. Green, R. Vargas, Melanie Espenshade, Paulette Ceesay, J. Alexander, A. Goldberg (2001)
Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.Clinical therapeutics, 23 8
F. Sacks, L. Svetkey, W. Vollmer, L. Appel, G. Bray, D. Harsha, E. Obarzanek, P. Conlin, E. Miller, D. Simons-Morton, N. Karanja, P. Lin, M. Aickin, Marlene Most-Windhauser, T. Moore, M. Proschan, J. Cutler (2001)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) dietThe New England Journal of Medicine, 344
A. Tenenbaum, E. Grossman, J. Shemesh, E. Fisman, I. Nosrati, M. Motro (2000)
Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough.American journal of hypertension, 13 7
L. Hansson, A. Zanchetti, S. Carruthers, B. Dahlöf, D. Elmfeldt, S. Julius, J. Ménard, K. Rahn, H. Wedel, S. Westerling (1998)
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 351
Pd redaction (2002)
Treatment of hypertension in adults with diabetes.Diabetes care, 25 1
R. Schwartz (2001)
Racial profiling in medical research.The New England journal of medicine, 344 18
L. Hebert, J. Kusek, T. Greene, L. Agodoa, C. Jones, A. Levey, J. Breyer, P. Faubert, H. Rolin, Shin-Ru Wang (1997)
Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and WhitesHypertension, 30
H. Gerstein, J. Mann, J. Pogue, S. Dinneen, J. Hallé, B. Hoogwerf, C. Joyce, A. Rashkow, James Young, B. Zinman, S. Yusuf (2000)
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.Diabetes care, 23 Suppl 2
M. Cirillo, Luigi Senigalliesi, M. Laurenzi, R. Alfieri, J. Stamler, R. Stamler, W. Panarelli, N. Santo (1998)
Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.Archives of internal medicine, 158 17
L. Appel, T. Moore, T. Moore, E. Obarzanek, W. Vollmer, L. Svetkey, F. Sacks, G. Bray, T. Vogt, J. Cutler, M. Windhauser, P. Lin, N. Karanja, D. Simons-Morton, M. McCullough, J. Swain, P. Steele, M. Evans, E. Miller, D. Harsha (1997)
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.The New England journal of medicine, 336 16
(2003)
American Medical Association. All rights reserved
(2000)
Heart and Stroke Statistical Update
W. Kannel, D. McGee, T. Gordon (1976)
A general cardiovascular risk profile: the Framingham Study.The American journal of cardiology, 38 1
Stephen Glasser, S. Chrysant, John Graves, B. Rofman, Donna Koehn (1989)
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.American journal of hypertension, 2 3 Pt 1
N. Brown, W. Ray, M. Snowden, M. Griffin (1996)
Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedemaClinical Pharmacology & Therapeutics, 60
E. Lewis, L. Hunsicker, W. Clarke, T. Berl, M. Pohl, J. Lewis, E. Ritz, R. Atkins, R. Rohde, I. Raz (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.The New England journal of medicine, 345 12
R. Fogari, L. Corea, O. Cardoni, F. Cosmi, C. Porcellati, P. Innocenti, M. Provvidenza, M. Timio, M. Bentivoglio, F. Bertocchi, A. Zoppi (1997)
Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.Journal of cardiovascular pharmacology, 30 4
W. Frishman, B. Bryzinski, L. Coulson, V. DeQuattro, N. Vlachakis, W. Mroczek, G. Dukart, J. Goldberg, D. Alemayehu, K. Koury (1994)
A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.Archives of internal medicine, 154 13
G. Bakris (1999)
Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.Journal of clinical hypertension, 1 2
W. Cushman, D. Reda, H. Perry, David Williams, M. Abdellatif, B. Materson (2000)
Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.Archives of internal medicine, 160 6
R. Pedrinelli, G. Dell'omo, V. Bello, R. Pontremoli, M. Mariani (2002)
Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertensionJournal of Human Hypertension, 16
S. Sheps (1997)
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.Archives of internal medicine, 157 21
S. Gottlieb, R. McCarter, R. Vogel (1998)
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.The New England journal of medicine, 339 8
H. Parving, Hendrik Lehnert, J. Bröchner-Mortensen, R. Gomis, S. Andersen, P. Arner (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.The New England journal of medicine, 345 12
M. Weir, D. Hanes (1996)
Hypertension in African Americans: a paradigm of metabolic disarray.Seminars in nephrology, 16 2
G. Bakris, J. Copley, N. Vicknair, R. Sadler, S. Leurgans (1996)
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.Kidney international, 50 5
G. Scally (1988)
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.British Medical Journal, 297
J. Wright, G. Bakris, T. Greene, L. Agodoa, L. Appel, J. Charleston, D. Cheek, Janice Douglas-Baltimore, J. Gassman, R. Glassock, L. Hebert, K. Jamerson, J. Lewis, R. Phillips, R. Toto, J. Middleton, S. Rostand (2002)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.JAMA, 288 19
D. Abernethy, J. Schwartz (1999)
Calcium-antagonist drugs.The New England journal of medicine, 341 19
W. Kannel (2000)
Elevated systolic blood pressure as a cardiovascular risk factor.The American journal of cardiology, 85 2
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA, 289 19
B. Davis (2000)
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.JAMA, 283 15
D. Maki, Jennie Ma, T. Louis, B. Kasiske (1995)
Long-term effects of antihypertensive agents on proteinuria and renal function.Archives of internal medicine, 155 10
R. D’Agostino, R. D’Agostino, S. Grundy, L. Sullivan, L. Sullivan, P. Wilson, P. Wilson (2001)
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.JAMA, 286 2
L. Prisant, G. Mensah (1996)
Use of β ‐ Adrenergic Receptor Blockers in BlacksThe Journal of Clinical Pharmacology, 36
E. Braunwald, E. Antman, J. Beasley, R. Califf, M. Cheitlin, J. Hochman, Robert Jones, D. Kereiakes, J. Kupersmith, T. Levin, C. Pepine, J. Schaeffer, E. Smith, D. Steward, P. Théroux, R. Gibbons, J. Alpert, K. Eagle, D. Faxon, V. Fuster, T. Gardner, G. Gregoratos, R. Russell, Sidney Smith (2000)
ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendationsCatheterization and Cardiovascular Interventions, 51
D. Sica, J. Douglas (2001)
The African American Study of Kidney Disease and Hypertension (AASK): New FindingsThe Journal of Clinical Hypertension, 3
MahendrS. Kochar, R. Guthrie, J. Triscari, K. Kassler-Taub, R. Reeves (1999)
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.American journal of hypertension, 12 8 Pt 1
T. Lüscher, B. Waeber (1993)
Efficacy and Safety of Various Combination Therapies Based on a Calcium Antagonist in Essential Hypertension: Results of a Placebo‐Controlled Randomized TrialJournal of Cardiovascular Pharmacology, 21
Cesar Chavez, Cesar Chavez (2001)
[Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2 11
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.The New England Journal of Medicine, 342
A. Manley (2004)
Physical Activity And Health: A Report Of The Surgeon General
L. Appel, M. Espeland, L. Easter, Alan Wilson, S. Folmar, C. Lacy (2001)
Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).Archives of internal medicine, 161 5
J. Gainer, J. Nadeau, D. Ryder, N. Brown (1996)
Increased sensitivity to bradykinin among African Americans.The Journal of allergy and clinical immunology, 98 2
D. Exner, D. Dries, D. Dries, M. Domanski, J. Cohn (2001)
Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.The New England journal of medicine, 344 18
J. Lewis, T. Berl, R. Bain, R. Rohde, E. Lewis (1999)
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.American journal of kidney diseases : the official journal of the National Kidney Foundation, 34 5
(2003)
REPRINTED) ARCH INTERN MED WWW.ARCHINTERNMED.COM
J. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, P. Clausen, M. Appleyard, G. Jensen (1997)
Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individualsJournal of Human Hypertension, 11
E. Saunders, M. Weir, B. Kong, J. Hollifield, James Gray, V. Vertes, J. Sowers, M. Zemel, C. Curry, J. Schoenberger, J. Wright, W. Kirkendall, E. Conradi, P. Jenkins, B. McLean, B. Massie, G. Berenson, W. Flamenbaum (1990)
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.Archives of internal medicine, 150 8
D. Sica, G. Bakris (2002)
Type 2 Diabetes: RENAAL and IDNT—The Emergence of New Treatment OptionsThe Journal of Clinical Hypertension, 4
H. Parving, E. Hommel, B. Jensen, H. Hansen (2001)
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.Kidney international, 60 1
L. Hansson, L. Lindholm, T. Ekbom, B. Dahlöf, J. Lanke, B. Scherstén, P. Wester, T. Hedner, U. Faire (1999)
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 studyThe Lancet, 354
R. Vasan, M. Larson, E. Leip, W. Kannel, D. Levy (2001)
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort studyThe Lancet, 358
V. Stevens, E. Obarzanek, N. Cook, I. Lee, L. Appel, Delia West, N. Milas, M. Mattfeldt-Beman, L. Belden, C. Bragg, Marian Millstone, J. Raczynski, A. Brewer, Bali Singh, Jerome Cohen (2001)
Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase IIAnnals of Internal Medicine, 134
T. Kotchen, D. McCarron (1998)
Dietary electrolytes and blood pressure: a statement for healthcare professionals from the American Heart Association Nutrition Committee.Circulation, 98 6
R. Schrier, R. Estacio, A. Esler, P. Mehler (2002)
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.Kidney international, 61 3
A. Richardson, R. Piepho (2000)
Effect of race on hypertension and antihypertensive therapy.International journal of clinical pharmacology and therapeutics, 38 2
Jiang He, P. Whelton (1999)
Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials.American heart journal, 138 3 Pt 2
J. Izzo, D. Levy, H. Black (2000)
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans.Hypertension, 35 5
J. Neaton, R. Grimm, R. Prineas, J. Stamler, G. Grandits, P. Elmer, J. Cutler, J. Flack, J. Schoenberger, R. Mcdonald, C. Lewis, P. Liebson (1993)
Treatment of Mild Hypertension Study: Final ResultsJAMA, 270
G. Fletcher, G. Balady, V. Froelicher, L. Hartley, W. Haskell, M. Pollock (1990)
Exercise standards. A statement for health professionals from the American Heart Association.Circulation, 82 6
C. Hennekens, M. Dyken, V. Fuster (1997)
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association.Circulation, 96 8
Erik Cohen, A. Soliman (2001)
Changing Trends in AngioedemaAnnals of Otology, Rhinology & Laryngology, 110
L. Køber, C. Torp-Pedersen, J. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbæk, D. Cole, L. Auclert, N. Pauly, E. Aliot, S. Persson, A. Camm (1995)
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.The New England journal of medicine, 333 25
(2001)
American Diabetes Association Clinical Practice Recommendations 2001.Diabetes care, 24 Suppl 1
G. Bakris, Mark Williams, L. Dworkin, W. Elliott, Murray Epstein, R. Toto, K. Tuttle, J. Douglas, Willa Hsueh, J. Sowers (2000)
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.American journal of kidney diseases : the official journal of the National Kidney Foundation, 36 3
J. Demirovic (1997)
Public Health Aspects of Out-of-Hospital Sudden Cardiac Arrest Among Elderly African-Americans.The American journal of geriatric cardiology, 6 5
J. Neaton, R. Grimm, R. Prineas, J. Stamler, G. Grandits, P. Elmer, J. Cutler, J. Flack, J. Schoenberger, R. Mcdonald (1993)
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.JAMA, 270 6
G. Berenson, A. Voors, L. Webber, E. Dalferes, D. Harsha (1979)
Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study.Metabolism: clinical and experimental, 28 12
B. Materson, D. Reda, David Williams (1996)
Lessons from combination therapy in Veterans Affairs Studies. Department of Veterans Affairs Cooperative Study Group on antihypertensive agents.American journal of hypertension, 9 12 Pt 2
Manyari De (1990)
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.The New England journal of medicine, 323 24
G. Fletcher, G. Balady, V. Froelicher, L. Hartley, W. Haskell, M. Pollock (1995)
Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group.Circulation, 91 2
P. Tatti, M. Pahor, R. Byington, P. Mauro, R. Guarisco, G. Strollo, F. Strollo (1998)
Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDMDiabetes Care, 21
C. Law, A. Shiell (1996)
Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literatureJournal of Hypertension, 14
K. Chatterjee, J. Daley, J. Douglas, S. Fihn, J. Gardin, Mark Grunwald, D. Levy, B. Lytle, R. O'rourke, William Schafer, Sankey Williams, J. Ritchie, R. Gibbons, M. Cheitlin, K. Eagle, T. Gardner, A. Garson, R. Russell, T. Ryan, Sidney Smith (1999)
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina).Circulation, 99 21
Solvd Investigators, S. Yusuf, B. Pitt, C. Davis, W. Hood, J. Cohn (1992)
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.The New England journal of medicine, 327 10
J. Flack, R. Grimm, B. Staffileno, Dnsc, P. Elmer, C. Yunis, Lowell Hedquist, A. Dudley (2002)
New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio.Ethnicity & disease, 12 1
A. Roca-Cusachs, F. Torres, M. Horas, J. Ríos, G. Calvo, J. Delgadillo, Maite Terán (2001)
Nitrendipine and Enalapril Combination Therapy in Mild to Moderate Hypertension: Assessment of Dose-Response Relationship by a Clinical Trial of Factorial DesignJournal of Cardiovascular Pharmacology, 38
W. Keane, G. Eknoyan (1999)
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.American journal of kidney diseases : the official journal of the National Kidney Foundation, 33 5
J. Cohn, G. Tognoni (2001)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.The New England journal of medicine, 345 23
C. Furberg, J. Wright, B. Davis, J. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. Haywood, F. Leenen, S. Oparil, J. Probstfield, P. Whelton, C. Nwachuku, D. Gordon, M. Proschan, Paula Einhom, C. Ford, L. Piller, I. Dunn, D. Goff, S. Pressel, Judy Bettencourt, Barbara DeLeon, Lara Simpson, J. Blanton, T. Geraci, Sandra Walsh, C. Nelson, Mahboob Rahman, Anne Juratovac, R. Pospíšil, L. Carroll, Sheila Sullivan, J. Russo, G. Barone, Rudy Christian, S. Feldman, T. Lucente, D. Calhoun, Kimo Jenkins, Peggy McDowell, Janice Johnson, C. Kingry, J. Alzate, K. Margolis, Leslie Holland-Klemme, B. Jaeger, J. Williamson, G. Louis, Pamela Ragusa, A. Williard, R. Ferguson, J. Tanner, J. Eckfeldt, R. Crow, J. Pelosi (2002)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA, 288 23
2001 Heart and Stroke Statistical Update.
J. Lee, P. Greene, M. Douglas, C. Grim, K. Kirk, J. Kusek, S. Milligan, D. Smith, P. Whelton (1996)
Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.Controlled clinical trials, 17 4 Suppl
(2000)
All rights reserved. comes Prevention Evaluation Study
aymond, E. O., Stacio, Arrett, J. W, Effers, Illiam, H. R., Iatt, Tacy, B. L., Iggerstaff, Obert, S. W, Chrier (2000)
THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION
J. McGill, P. Reilly (2001)
Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.Clinical therapeutics, 23 6
R. Turner, R. Holman (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.BMJ
Matthew Weir, David Smith, J. Neutel, M. Bedigian (2001)
Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake.American journal of hypertension, 14 7 Pt 1
H. Dargie (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialThe Lancet, 357
L. Agodoa, L. Appel, G. Bakris, G. Beck, J. Bourgoignie, J. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. Douglas, M. Douglas, D. Dowie, M. Faulkner, Avril Gabriel, J. Gassman, T. Greene, Y. Hall, L. Hebert, L. Hiremath, K. Jamerson, C. Johnson, J. Kopple, J. Kusek, J. Lash, J. Lea, J. Lewis, M. Lipkowitz, S. Massry, J. Middleton, E. Miller, Keith Norris, D. O'Connor, A. Ojo, R. Phillips, V. Pogue, Mahboob Rahman, O. Randall, S. Rostand, G. Schulman, W. Smith, D. Thornley‐Brown, C. Tisher, R. Toto, J. Wright (2001)
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.JAMA, 285 21
E. Lewis, L. Hunsicker, R. Bain, R. Rohde (1993)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.The New England journal of medicine, 329 20
R. Levine, J. Foster, R. Fullilove, M. Fullilove, N. Briggs, P. Hull, B. Husaini, C. Hennekens (2001)
Black-White Inequalities in Mortality and Life Expectancy, 1933–1999: Implications for Healthy People 2010Public Health Reports, 116
J. Tuomilehto, D. Rastenytė, W. Birkenhäger, L. Thijs, R. Antikainen, C. Bulpitt, A. Fletcher, F. Forette, A. Goldhaber, P. Palatini, C. Sarti, R. Fagard (1999)
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic HypertensionThe New England Journal of Medicine, 340
W. Elliott (1996)
Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjectsClinical Pharmacology & Therapeutics, 60
P. Wilson, R. D’Agostino, Daniel Levy, Albert Belanger, H. Silbershatz, W. Kannel (1998)
Prediction of coronary heart disease using risk factor categories.Circulation, 97 18
M. Weir (1995)
Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective.American journal of hypertension, 8 6
D. Hilleman, K. Ryschon, S. Mohiuddin, R. Wurdeman (1999)
Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluationJournal of Human Hypertension, 13
Detection (1997)
The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)JAMA Internal Medicine, 157
L. Prisant, G. Mensah (1996)
Use of beta-adrenergic receptor blockers in blacks.Journal of clinical pharmacology, 36 10
R. Morris, A. Sebastian, A. Forman, Masae Tanaka, O. Schmidlin (1999)
Normotensive salt sensitivity: effects of race and dietary potassium.Hypertension, 33 1
A. Fournier, J. Lalau (1994)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.The New England journal of medicine, 330 13
Sidney Smith, P. Greenland, S. Grundy (2000)
Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive SummaryCirculation, 101
L. Haywood (1984)
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.American heart journal, 108 3 Pt 2
B. Dahlöf, R. Devereux, S. Kjeldsen, S. Julius, G. Beevers, U. Faire, F. Fyhrquist, H. Ibsen, Krister Kristiansson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 359
R. Stamler, A. Nissinen, U. Uusitalo, G. Rose, P. Pietinen, J. Stamler (1988)
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.BMJ
J. Flack, S. Oparil, J. Pratt, B. Roniker, S. Garthwaite, J. Kleiman, Yonghong Yang, S. Krause, D. Workman, E. Saunders (2003)
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.Journal of the American College of Cardiology, 41 7
S. Oliveria, P. Lapuerta, B. McCarthy, G. L’italien, D. Berlowitz, S. Asch (2002)
Physician-related barriers to the effective management of uncontrolled hypertension.Archives of internal medicine, 162 4
F. Messerli, S. Oparil, Zhanbin Feng (2000)
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.The American journal of cardiology, 86 11
S. Grundy, R. Pasternak, P. Greenland, S. Smith, V. Fuster (1999)
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.Circulation, 100 13
E. Grossman, F. Messerli, U. Goldbourt (2000)
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?Archives of internal medicine, 160 16
G. Bakris, A. Mangrum, J. Copley, N. Vicknair, R. Sadler (1997)
Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.Hypertension, 29 3
D. Powers, J. Wallin (1998)
End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy.Archives of internal medicine, 158 7
S. MacMahon, B. Neal, C. Tzourio, A. Rodgers, M. Woodward, J. Cutler, C. Anderson, J. Chalmers, T. Ohkubo (2001)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attackThe Lancet, 358
(2000)
ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 51 4
J. Cleland, L. Erhardt, G. Murray, A. Hall, S. Ball (1997)
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.European heart journal, 18 1
James Pool, William Cushman, R. Saini, C. Nwachuku, J. Battikha (1997)
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.American journal of hypertension, 10 1
L. Lindholm, H. Ibsen, B. Dahlöf, R. Devereux, G. Beevers, U. Faire, F. Fyhrquist, S. Julius, S. Kjeldsen, Krister Kristiansson, O. Lederballe‐Pedersen, M. Nieminen, P. Omvik, S. Oparil, H. Wedel, P. Aurup, J. Edelman, S. Snapinn (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 359
J. Chalmers, B. Neal (1999)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.Journal of hypertension, 17 2
D. Young-Hyman, D. Schlundt, L. Herman, F. Luca, D. Counts (2001)
Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children.Diabetes care, 24 8
J. Staessen, R. Fagard, L. Thijs, H. Celis, G. Arabidze, W. Birkenhäger, C. Bulpitt, P. Leeuw, C. Dollery, A. Fletcher, F. Forette, G. Leonetti, C. Nachev, E. Brien, J. Rosenfeld, J. Rodicio, J. Tuomilehto, A. Zanchetti (1997)
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 350
J. Flack, G. Mensah, C. Ferrario (2000)
Using Angiotensin Converting Enzyme Inhibitors in African-American Hypertensives: A New Approach to Treating Hypertension and Preventing Target-Organ DamageCurrent Medical Research and Opinion, 16
Jiang He, P. Whelton (1999)
Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 17 2
R. Krauss, R. Eckel, B. Howard, L. Appel, S. Daniels, R. Deckelbaum, J. Erdman, P. Kris-Etherton, I. Goldberg, T. Kotchen, A. Lichtenstein, W. Mitch, R. Mullis, K. Robinson, J. Wylie-Rosett, S. Jeor, J. Suttie, D. Tribble, T. Bazzarre (2000)
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.Circulation, 102 18
R. Vasan, J. Massaro, P. Wilson, S. Seshadri, P. Wolf, D. Levy, R. D'Agostino (2002)
Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart StudyCirculation: Journal of the American Heart Association, 105
SPECIAL ARTICLE Management of High Blood Pressure in African Americans Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks Janice G. Douglas, MD; George L. Bakris, MD; Murray Epstein, MD; Keith C. Ferdinand, MD; Carlos Ferrario, MD; John M. Flack, MD, MPH; Kenneth A. Jamerson, MD; Wendell E. Jones, MD; Julian Haywood, MD; Randall Maxey, MD; Elizabeth O. Ofili, MD; Elijah Saunders, MD; Ernesto L. Schiffrin, MD, PhD; Domenic A. Sica, MD; James R. Sowers, MD; Donald G. Vidt, MD; the Hypertension in African Americans Working Group he purpose of this consensus statement is to offer primary care providers (including physicians, nurse practitioners, and physician assistants) a practical, evidence-based clinical tool for achieving blood pressure goals in African American patients. The need T for specific recommendations for African Americans is highlighted by compelling evi- dence of a higher prevalence of hypertension and poorer cardiovascular and renal outcomes in this group than in white Americans. African Americans have disturbingly higher rates of cardio- vascular mortality, stroke, hypertension-related heart disease, congestive heart failure, type 2 dia- 1,2 betes mellitus, hypertensive nephropathy, and end-stage renal disease (ESRD). Large population-based studies have dem- 85-89
JAMA Internal Medicine – American Medical Association
Published: Mar 10, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.